Trials / Completed
CompletedNCT01918462
Protective Immune Mechanisms in Alcoholic Hepatitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 51 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 18 Years – 69 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the production, effects and interactions of the hepato-protective cytokine interleukine (IL)-22 in patients with alcoholic hepatitis.
Detailed description
The investigators will study hepatic biopsies from patients with alcoholic hepatitis. In these biopsies, the investigators will assess the production of IL-22 and which cells produce the cytokine. The investigators will study the expression of the IL-22 receptor and also the production of the IL-22 binding protein, which can inhibit the actions of the cytokine.
Conditions
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2018-04-20
- Completion
- 2018-04-20
- First posted
- 2013-08-07
- Last updated
- 2021-04-29
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01918462. Inclusion in this directory is not an endorsement.